A Review on Recent Advances in Drug Development and Pharmacotherapeutic Approaches for Obesity

Journal Title: Journal of Medical Science And clinical Research - Year 2014, Vol 2, Issue 6

Abstract

Overweight and obesity are defined as abnormal or excessive fat accumulation that presents a risk to health. A crude population measure of obesity is the body mass index (BMI) . A person with a BMI of 30 or more is generally considered obese. A person with a BMI equal to or more than 25 is considered overweight. Obesity is a well-established risk factor for hypertension, hyperlipidemia, type II diabetes, coronary heart disease, stroke, obstructive sleep apnea, asthma, orthopedic disorders, and certain cancers. Despite this risk, the prevalence of obesity continues to increase worldwide, and there is a growing demand for safe and effective antiobesity drugs. Previous antiobesity drugs or anorexigens, particularly centrally acting agents, have poor safety records. Life-threatening safety issues led to the withdrawal of aminorex in 1968, fenfluramine and dexfenfluramine in 1997, and phenyl propanolamine in 2000. Many of the safety issues, such as valvulopathy with fenfluramine and pulmonary arterial hypertension with aminorex, were initially not predicted by routine preclinical toxicology studies. . Meridian(Sibutramine ) was approved by FDA in 1987,Xenical (orlistat) was approved by FDA in 1999, Recently Qsymia (phentermine & topiramate), Belviq(lorcaserin) was approved by FDA in 2012. This review covers the current state of antiobesity drugs and their safety concerns, and highlights new therapeutic targets and also highlights the threats associated with the surgical treatment of obesity as how liposuction surgery recently claim life of JNTU assistant professor.

Authors and Affiliations

Ayesha Siddiqua

Keywords

Related Articles

A Study of Correlation of Peak Expiratory Flow Rate with Body Mass Index in Healthy School Going Children

Introduction: Peak expiratory flow rate is the maximum rate at which the air can be expired after deep inspiration and it is an effort dependent parameter. PEFR is measured to detect the cardiorespiratory efficiency of a...

Clinicopathological Study of Mass in Right Iliac Fossa

The present study was done to know the various diseases which can present with mass in the right iliac fossa and also to study the modes of investigations available to diagnose various types of mass in right iliac fossa...

Brucellosis: Presentation, Diagnosis and Treatment: Case Report

Introduction: Brucellosis is one of the commonest zoonotic infections worldwide. the disease is endemic in Saudi Arabia, the Middle East, and the Mediterranean area, and whether in an endemic region or not, it remains a...

A Prospective Study of Treatment Outcomes for Amblyopia

Amblyopia is the most common cause of monocular visual impairment in children and young- and middle-aged adults.1,2 Anisometropia, as the most frequent cause of amblyopia, has been evaluated in numerous studies.3- 5 Howe...

Quadruplet Pregnancy Following Spontaneous Conception: A Rare Case Report

Higher order (triplet or more) multiple pregnancies occur when more than two fetuses are present in the uterus at the same time. Quadruplets are a set of four offspring born at one birth which can be fraternal (multizygo...

Download PDF file
  • EP ID EP205947
  • DOI -
  • Views 95
  • Downloads 0

How To Cite

Ayesha Siddiqua (2014). A Review on Recent Advances in Drug Development and Pharmacotherapeutic Approaches for Obesity. Journal of Medical Science And clinical Research, 2(6), 1299-1313. https://europub.co.uk/articles/-A-205947